Haematologica 2003 - Supplements
Haematologica 2003 - Supplements
Haematologica 2003 - Supplements
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
was associated with I.V. line, while 4 (30.8 %) were identified<br />
postoperatively. We identified several univariable correlates in<br />
MGUS patients, including family (HR-13.79, P= .014) and<br />
personal (HR-8.95, P=. 002) history of DVT, low serum albumin<br />
(HR-4.21, P=. 018) and increased white blood cells count (HR-<br />
3.41, P=. 032). IgG immunoglobulin type was protective in our<br />
analysis (HR-0.19, P=. 017). None of the patients received any<br />
type of active treatment for their disaese. In conclusion, risk for<br />
thromboembolic diseases in patients with MGUS is increased as<br />
compared to general population, and is similar to incidence in<br />
MM patients (10%). Further studies are necessary to define the<br />
mechanisms involved.<br />
098<br />
Amyloidosis and Deep Venous Thrombosis (DVT)<br />
Gordan Srkalovic, Marte A. Cameron, Lisa Rybicki and<br />
Mohamad A. Hussein<br />
Cleveland Clinic Foundation Multiple Myeloma Research Program<br />
Coagulation problems in Amyloidosis are historically associated<br />
with bleeding tendencies (mostly F X abnormalities). Increased<br />
clotting was observed in isolated cases diagnosed with low grade<br />
DIC. Problem of DVT in Amyloidosis was not systematically<br />
investigated. We evaluated frequency of DVT and risk factors for<br />
DVT in 56 consecutive Amyloidosis patients with a documented<br />
disease evaluated and followed up at our Center from 1991-2001.<br />
Data were collected in 5 categories: (a) demographics, (b) disease<br />
and treatment, (c) thrombosis case information, (d) major risk<br />
factors for thrombosis and (e) baseline laboratory data. Uni- and<br />
multivariable correlates of DVT were assessed using Kaplan-<br />
Meier analysis and Cox proportional hazards analysis. Mean age<br />
of the patients was 61.8 (range 21 – 83). Male female percentage<br />
ratio was 70/30. 30 % of the patients had high creatinine level (><br />
1.4 mg/dl). Personal or family history of DVT was recorded in<br />
1.8 and 0 % of patients, respectively. Known hypercoagulable<br />
state was present in 1 patient (1.8%). 7.6 % of patients were<br />
smokers. Of 56 patients 6 developed DVT (10.7%). Median<br />
time from diagnosis to DVT was 12.5 month (range 1-107).<br />
Treatment was given within 1.4 months (range 0-4) from the<br />
development of thrombosis. Only sites of DVT were lower<br />
extremities. No cases were associated with I.V. line. 1 (16.7 %)<br />
was identified postoperatively. We identified several univariable<br />
correlates of DVT in Amyloid patients, including age at<br />
diagnosis (HR-2.99, P=. 041), personal history of DVT (HR-47.7,<br />
P=.006), immobility (HR-11.78, P=.006). Paradoxically, presence<br />
of circulating serum M-protein had protective role in our analysis<br />
(HR-.08, 95% confidence interval .01-. 80, P=. 031). There was<br />
no correlation with the type of treatment patients was receiving.<br />
Family and personal history of DVT were also identified as risk<br />
factors in multivariable analysis of whole group (668) of patients<br />
with plasma cell dyscrasias. In conclusion, risk for<br />
thromboembolic diseases in patients with Amyloidosis is<br />
identical to one previously described for MM patients (10%).<br />
Further studies are necessary to define pathophysiological<br />
processes involved.<br />
099<br />
Disturbances of Anticoagulation and Fibrinolytic<br />
Systems in Monoclonal Gammapathies - Another<br />
Mechanism of M-protein Interference with Hemostasis.<br />
Ivan Spicka, Zuzana Rihova, Petr Cieslar, Bohumir<br />
Prochazka *<br />
Ist Department of Internal Medicine, Department of Hematology,<br />
General Faculty Hospital, Charles University, Prague, Czech rep; *<br />
National Institute of Public Health, Prague, Czech rep. Phone: +<br />
420-2- 24962551; Fax: + 42-2-297932; e-mail: spicka@cesnet.cz<br />
Monoclonal gammapathies (MG) may be associated with unique<br />
M-protein induced disturbances of either primary hemostasis or<br />
plasma coagulation. We have investigated the possible<br />
interference of M-protein with antithrombotic systems. Decrease<br />
of antithrombin III, protein C, protein S and plasminogen levels<br />
or defect of APC resistance was found in 26.5% of patients.<br />
However, higher tissue-type plasminogen activator (t-PA)<br />
activity was the most frequent abnormality. The relationship<br />
between M-protein type and concentration and frequency of<br />
antithrombotic factor abnormalities was not found. The risk of<br />
venous thrombosis was higher in patients with the defect in<br />
comparison with the unaffected group (46% vs. 22%) but the<br />
difference was not statistically significant. Bleeding<br />
complications were markedly less frequent in the group of<br />
patients with the defect of anticoagulation mechanisms (0% vs.<br />
17%). In conclusion, we have found the defects of<br />
anticoagulation and/or fibrinolytic system, analogous to wellknown<br />
disturbances in hemostatic mechanisms, in more than a<br />
quarter of patients with MG. The interference of M-protein with<br />
coagulations inhibitors and/or fibrinolytic systems could<br />
contribute to the development of thromboembolic events.<br />
100<br />
Occupation, Pesticide Exposure and Risk of Multiple<br />
Myeloma<br />
D. Baris1, D.T. Silverman1, L.M. Brown1, G.M. Swanson2,<br />
R.B. Hayes1, A.G. Schwartz3, J.M. Liff4, J.B.<br />
Schoenberg5, L. M. Pottern6, R.S. Greenberg7, P.A.<br />
Stewart1.<br />
1Div. of Cancer Epidemiology and Genetics, NCI, NIH, DHHS,<br />
Bethesda, MD; 2Cancer Center, Michigan State University, E. Lansing,<br />
MI;3Wayne State University, School of Medicine and the Karmanos<br />
Cancer Institute, Detroit, MI; 4Rollins School of Public Health, Emory<br />
University, Atlanta, GA; 5New Jersey State Department of Health,<br />
Trenton, NJ; 6Women`s Health Initiative, NIHLB, NIH, DHHS,<br />
Bethesda, MD; 7Medical University of South Carolina, Charleston, SC.<br />
In this population-based case-control study, we examined the<br />
relationship between occupation, farm history, pesticide exposure<br />
and risk of multiple myeloma among blacks and whites in the<br />
U.S. The study included 573 cases (206 blacks and 367 whites)<br />
newly diagnosed with myeloma between 1986 and 1989 and<br />
2,131 controls (967 blacks and 1,164 whites) from three U.S.<br />
geographic areas. Detailed information was obtained on sociodemographic<br />
factors, occupational and farm history, dietary<br />
factors, smoking, and medical history. Information on usual<br />
occupation and industry were coded according to standardized<br />
classification systems. A job/industry exposure matrix (JEM)<br />
was developed to estimate the level of occupational exposure to<br />
pesticides. Odds ratios (ORs) and 95% confidence intervals (CIs)<br />
for the analyses of occupational and farm history and pesticide<br />
exposure were estimated by unconditional logistic regression.<br />
Farmers and farm workers had ORs of 1.9 (95% CI=0.8-4.6) and<br />
1.4 (95% CI=0.8-2.3), respectively. An OR of 1.7 (95% CI=1.0-<br />
2.7) was observed among those who lived or worked on a farm<br />
S132